News

Here’s why most of the claims recently made about antidepressants in Newsweek are wrong.

The first patient in a phase 2/3 study evaluating ulotaront for MDD has been enrolled.

Merriam-Webster’s Word of 2022: gaslighting.

Perhaps we should try to act more like manatees…

Don’t grow old in your relationship, grow bold.

New research finds that a urine test for formic acid could detect early-stage Alzheimer disease.

The drug is in development for the treatment of acute depressive disorders and depression with suicidality.

The phase 3 SERENITY III trial investigating at-home use of dexmedetomidine (BXCL501) sublingual film for agitation associated with bipolar I or II disorder or schizophrenia has started.

The experts weighed in on a wide variety of psychiatric issues for the November 2022 issue of Psychiatric Times.

In this CME article, learn how to apply novel treatment approaches for patients with bipolar depression.

Acknowledging the impact of holidays on others, and what to do when things get dark.

Do you know these terms?

Psychiatrists are in a unique position to empower their patients by recognizing and addressing key issues surrounding gender and sexuality.

What would it take for psychiatrists and other physicians in the United States to collectively resist risks to the public’s health and mental health?

An update from Ukraine.

"Our own implicit biases come into play at times whether we like it or not, especially when it comes to frequently controversial medications."

Psychiatry and inner space—closer than you think.

Tell us about your holiday traditions for a chance to be featured in our Holiday Traditions series.

From the unique challenges of treating physician-patients to updates on MDMA and psilocybin research and access, here are highlights from the week in Psychiatric Times.

New research explores the impact of GAT on TGNC youth.

The two sides of the Thanksgiving coin… what are they and what do they mean?

Have you missed the latest episodes of the series Tales From the Clinic: The Art of Psychiatry?

How can you foster gratitude in your patients?

“Both doctors and patients know best.”

An important adverse effect of SRIs: their association with increased bleeding.

A new bill, the Breakthrough Therapies Act, would encourage the reclassification of MDMA and psilocybin from schedule I to schedule II drugs.

Combining Thanksgiving, Hanukkah, and December birthday celebrations for the ultimate unique family dinner.

While resilience is beneficial to mental health, we need to reduce the reasons individuals require resilience.

"This volume is a fascinating incursion into a field that everybody talks about, but few examine in depth."

Understanding and addressing the unmet therapeutic needs of individuals living with mental health conditions.